A look at cost-effectiveness.
Gibaldi
M
M
School of Pharmacy, University of Washington, Seattle 98195.
Sullivan
S D
SD
D000319:Adrenergic beta-Antagonists / Q000191:economics; D000959:Antihypertensive Agents / Q000191:economics; D000970:Antineoplastic Agents / Q000191:economics; D003287:Contrast Media / Q000191:economics; D003361:Cost Allocation; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004358:Drug Therapy / Q000191:economics* / Q000379:methods; D006801:Humans; D007362:Intensive Care Units / Q000191:economics; D017063:Outcome Assessment, Health Care; D014612:Vaccines / Q000191:economics
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D003287:Contrast Media; D014612:Vaccines